These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24737444)

  • 1. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
    Shaw C; Simms RJ; Pitcher D; Sandford R
    Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
    Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Caskey F; Collart F; Finne P; Fogarty DG; Groothoff JW; Hoitsma A; Nogier MB; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ; ; ;
    Kidney Int; 2014 Dec; 86(6):1244-52. PubMed ID: 24827775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.
    Webb L; Gilg J; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c85-96. PubMed ID: 21894042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Abad JM; Aresté N; de la Torre RA; Caskey F; Couchoud C; Finne P; Heaf J; Hoitsma A; de Meester J; Pascual J; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ;
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4(Suppl 4):iv15-25. PubMed ID: 25165182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Challenges of Using UK Renal Registry Data to Audit the Care of Patients with Diabetes on Renal Replacement Therapy.
    Cox L; Wong E; Evans KM; Medcalf J; Pyart R
    Nephron; 2020; 144(9):440-446. PubMed ID: 32698181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK Renal Registry 12th Annual Report (December 2009): chapter 6: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2003 to 2008: national and centre-specific analyses.
    Caskey F; Webb L; Gilg J; Fogarty D
    Nephron Clin Pract; 2010; 115 Suppl 1():c103-16. PubMed ID: 20413944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study.
    Haynes R; Kheradmand F; Winearls CG
    Nephron Clin Pract; 2012; 120(1):c42-7. PubMed ID: 22205054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012.
    Rao A; Steenkamp R; Caskey F
    Nephron Clin Pract; 2013; 125(1-4):99-110. PubMed ID: 24662169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International comparison of trends in patients commencing renal replacement therapy by primary renal disease.
    Stel VS; Awadhpersad R; Pippias M; Ferrer-Alamar M; Finne P; Fraser SD; Heaf JG; Hemmelder MH; Martínez-Castelao A; de Meester J; Palsson R; Prischl FC; Segelmark M; Traynor JP; Santamaria R; Reisaeter AV; Massy ZA; Jager KJ
    Nephrology (Carlton); 2019 Oct; 24(10):1064-1076. PubMed ID: 30456883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK Renal Registry 15th annual report: Chapter 5 survival and causes of death of UK adult patients on renal replacement therapy in 2011: national and centre-specific analyses.
    Steenkamp R; Shaw C; Feest T
    Nephron Clin Pract; 2013; 123 Suppl 1():93-123. PubMed ID: 23774488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
    Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 4 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2009 to 2010.
    Shaw C; Webb L; Casula A; Tomson CR
    Nephron Clin Pract; 2012; 120 Suppl 1():c81-91. PubMed ID: 22964575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New adult patients starting renal replacement therapy in the UK in 2005 (chapter 3).
    Farrington K; Rao R; Gilg J; Ansell D; Feest T
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii11-29. PubMed ID: 17724040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK Renal Registry 13th Annual Report (December 2010): Chapter 6: survival and causes of death of UK adult patients on renal replacement therapy in 2009: national and centre-specific analyses.
    Castledine C; Steenkamp R; Feest T; Tomson CR
    Nephron Clin Pract; 2011; 119 Suppl 2():c107-34. PubMed ID: 21894029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic comorbidities in autosomal dominant polycystic kidney disease: a 16-year retrospective cohort study.
    Chen LC; Chu YC; Lu T; Lin HY; Chan TC
    BMC Nephrol; 2023 Nov; 24(1):333. PubMed ID: 37946153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.
    Udayaraj U; Tomson CR; Gilg J; Ansell D; Fogarty D
    Nephron Clin Pract; 2009; 111 Suppl 1():c97-111. PubMed ID: 19542707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration.
    Hommel K; Rasmussen S; Madsen M; Kamper AL
    Nephrol Dial Transplant; 2010 Mar; 25(3):947-51. PubMed ID: 19861312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.
    Boddana P; Caskey F; Casula A; Ansell D
    Nephron Clin Pract; 2009; 111 Suppl 1():c269-76. PubMed ID: 19542702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.
    Martínez V; Comas J; Arcos E; Díaz JM; Muray S; Cabezuelo J; Ballarín J; Ars E; Torra R
    BMC Nephrol; 2013 Sep; 14():186. PubMed ID: 24007508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.